These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37439778)

  • 21. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
    Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
    Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.
    Bhati C; Idowu MO; Sanyal AJ; Rivera M; Driscoll C; Stravitz RT; Kohli DR; Matherly S; Puri P; Gilles H; Cotterell A; Levy M; Sterling RK; Luketic VA; Lee H; Sharma A; Siddiqui MS
    Transplantation; 2017 Aug; 101(8):1867-1874. PubMed ID: 28296807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
    van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
    Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Yuan L; Hanlon CL; Terrault N; Alqahtani S; Tamim H; Lai M; Saberi B
    Am J Gastroenterol; 2022 Mar; 117(3):433-444. PubMed ID: 35083985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
    Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation.
    Satapathy SK; Tran QT; Kovalic AJ; Bontha SV; Jiang Y; Kedia S; Karri S; Mupparaju V; Podila PSB; Verma R; Maluf D; Mas V; Nair S; Eason JD; Bridges D; Kleiner DE
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00302. PubMed ID: 33555168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.
    Sundaram V; Kogachi S; Wong RJ; Karvellas CJ; Fortune BE; Mahmud N; Levitsky J; Rahimi RS; Jalan R
    J Hepatol; 2020 Mar; 72(3):481-488. PubMed ID: 31669304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes With or Without Hypertension Does Not Affect Graft Survival and All-cause Mortality After Liver Transplant: A Propensity Score Matching Analysis.
    Kwon HM; Moon YJ; Jung KW; Sang BH; Hwang GS
    Transplant Proc; 2018 May; 50(4):1123-1128. PubMed ID: 29731078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes.
    Hejlova I; Honsova E; Sticova E; Lanska V; Hucl T; Spicak J; Jirsa M; Trunecka P
    Liver Transpl; 2016 May; 22(5):644-55. PubMed ID: 26707008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients.
    Krishnamoorthi R; Manickam P; Cappell MS
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):113-8. PubMed ID: 24780945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation.
    Tsochatzis E; Coilly A; Nadalin S; Levistky J; Tokat Y; Ghobrial M; Klinck J; Berenguer M
    Transplantation; 2019 Jan; 103(1):45-56. PubMed ID: 30153225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data.
    Wong RJ; Chou C; Bonham CA; Concepcion W; Esquivel CO; Ahmed A
    Clin Transplant; 2014 Jun; 28(6):713-21. PubMed ID: 24654688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.